Valuation: Seer, Inc.

Market Cap 115M 99.37M 93.38M 84.93M 160M 11B 162M 1.09B 428M 5.51B 432M 423M 18.31B P/E 2026 *
-1.89x
P/E 2027 * -2.04x
Enterprise Value 115M 99.37M 93.38M 84.93M 160M 11B 162M 1.09B 428M 5.51B 432M 423M 18.31B EV / Sales 2026 *
7.15x
EV / Sales 2027 * 5.93x
Free-Float
85.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.95%
1 week-4.15%
Current month-6.31%
1 month-3.70%
3 months+20.93%
6 months+2.97%
Current year+13.66%
1 week 2.02
Extreme 2.02
2.22
1 month 1.82
Extreme 1.82
2.25
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.74
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 01/09/2020
Director/Board Member 76 01/12/2017
Director/Board Member 70 01/12/2017
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

31,125 0.0563%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-4.15%+0.48%-22.68% 115M
-0.82%-0.73%+8.13%+15.67% 28.43B
-1.05%+3.51%+20.39%-0.57% 7.66B
+4.21%+9.53%+23.18%+139.55% 3.39B
+0.41%+0.36%+14.77%-46.00% 2.97B
-1.72%+6.58%+88.64%+89.48% 2.71B
+5.47%+6.83%+113.21%+138.00% 1.92B
+3.21%+0.87%+10.37%+21.14% 1.74B
-1.06%+11.58%+9.18%+58.99% 1.38B
-0.41%+0.63%+61.94%+70.45% 855M
Average +0.73%+3.10%+35.03%+46.40% 5.12B
Weighted average by Cap. -0.12%+2.34%+20.55%+28.55%

Financials

2026 *2027 *
Net sales 16.1M 13.91M 13.07M 11.88M 22.34M 1.54B 22.71M 153M 59.86M 771M 60.45M 59.14M 2.56B 19.4M 16.76M 15.75M 14.32M 26.92M 1.86B 27.37M 184M 72.13M 929M 72.84M 71.26M 3.09B
Net income -61.2M -52.86M -49.67M -45.17M -84.93M -5.85B -86.33M -582M -228M -2.93B -230M -225M -9.74B -57.7M -49.84M -46.83M -42.59M -80.07M -5.52B -81.39M -549M -215M -2.76B -217M -212M -9.18B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
14/08/26 $2.080 -0.95% 126,388
13/08/26 $2.100 -1.87% 529,708
12/08/26 $2.140 -0.93% 515,091
11/08/26 $2.160 0.00% 203,140
10/08/26 $2.160 -0.46% 150,883
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.080USD
Average target price
4.000USD
Spread / Average Target
+92.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock